IL6 and neoplasm: There are also studies focusing on specific cytokines, and the results all support that circulating cytokine levels have the potential to reflect the state of the tumor immune microenvironment and the clinical outcomes of ICI therapy, particularly IL-6 and INFγ levels [162–164].